Literature DB >> 7035394

Type I collagen and fibronectin synthesis by retrocorneal fibrous membrane.

E D Kay, C C Cheung, J V Jester, M E Nimni, R E Smith.   

Abstract

The primary cultures obtained from the experimentally induced retrocorneal fibrous membrane synthesized and secreted into the medium mainly type I procollagen. This collagen was characterized after limited pepsin treatment and identified as type I collagen by the following criteria: (1) it contained two alpha 1 chains and one alpha 2 chain, (2) its sedimentation behavior was identical to that of type I collagen from skin, and (3) its peptide map after limited proteolysis with Staphylococcus aureus V8 protease was identical to that of type I collagen. The medium contained procollagen I, which was converted into alpha size chains by limited pepsin treatment, whereas the cellular fraction contained type I collagen already processed to its end product. Type III collagen and basement membrane collagen were present as minor components in this system Fibronectin, one of the major glycoproteins in extracellular matrices, was also synthesized and secreted into the medium. In contrast, normal corneal endothelial cells produce mainly basement membrane collagen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035394

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Human corneal endothelial cells employ phosphorylation of p27(Kip1) at both Ser10 and Thr187 sites for FGF-2-mediated cell proliferation via PI 3-kinase.

Authors:  Jeong Goo Lee; Jong-Suk Song; Ronald E Smith; Eunduck P Kay
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

2.  In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition.

Authors:  Wei-Ting Ho; Chien-Chia Su; Jung-Shen Chang; Shu-Wen Chang; Fung-Rong Hu; Tzuu-Shuh Jou; I-Jong Wang
Journal:  J Vis Exp       Date:  2016-08-20       Impact factor: 1.355

3.  Fibroblast growth factor 2 induces proliferation and fibrosis via SNAI1-mediated activation of CDK2 and ZEB1 in corneal endothelium.

Authors:  Jeong Goo Lee; Eric Jung; Martin Heur
Journal:  J Biol Chem       Date:  2018-01-23       Impact factor: 5.157

4.  Posterior stromal cell apoptosis triggered by mechanical endothelial injury and basement membrane component nidogen-1 production in the cornea.

Authors:  Carla S Medeiros; Luciana Lassance; Paramananda Saikia; Marcony R Santhiago; Steven E Wilson
Journal:  Exp Eye Res       Date:  2018-03-27       Impact factor: 3.467

5.  PI 3-kinase/Rac1 and ERK1/2 regulate FGF-2-mediated cell proliferation through phosphorylation of p27 at Ser10 by KIS and at Thr187 by Cdc25A/Cdk2.

Authors:  Jeong Goo Lee; EunDuck P Kay
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

6.  Corneal endothelial cell abnormalities in an early stage of the iridocorneal endothelial syndrome.

Authors:  W R Lee; G E Marshall; C M Kirkness
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

7.  The spatial organization of Descemet's membrane-associated type IV collagen in the avian cornea.

Authors:  J M Fitch; D E Birk; C Linsenmayer; T F Linsenmayer
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

8.  Common and distinct pathways for cellular activities in FGF-2 signaling induced by IL-1beta in corneal endothelial cells.

Authors:  Jeong Goo Lee; EunDuck P Kay
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

9.  Corneal Fibroblast Migration Patterns During Intrastromal Wound Healing Correlate With ECM Structure and Alignment.

Authors:  W Matthew Petroll; Pouriska B Kivanany; Daniela Hagenasr; Eric K Graham
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

10.  Induction of FGF-2 synthesis by IL-1beta in aqueous humor through P13-kinase and p38 in rabbit corneal endothelium.

Authors:  Jong-Suk Song; Jeong Goo Lee; EunDuck P Kay
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.